Of Mice, Men and Stem-Cell Research
By Osagie K. Obasogie,
San Francisco Chronicle
| 02. 20. 2006
President Bush's State of the Union address highlighted several key policy issues, such as America's dependency on foreign oil, the ongoing war in Iraq and Baby Boomers' impact on Social Security. But the president's call for legislation to prohibit scientists from creating "animal-human hybrids" caught many by surprise; the term was one of the most popular Internet searches in the hours following his speech. Many wondered "What is the president talking about?" or "Why is he using his most important speech of the year to come out against science fiction?"
Bush's remarks may very well have been prompted by a recent article in the Proceedings of the National Academy of Sciences, which reported that researchers at the Salk Institute in La Jolla had created the first set of fully functioning human nerve cells in an animal by injecting human embryonic stem cells into mouse embryos. These mice now experience the world, at least in part, with cells similar to those you are now using to read this article. This is the first time human embryonic stem cells have been shown...
Related Articles
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...
By Jessica Hamzelou, MIT Technology Review | 11.07.2025
This week, we heard that Tom Brady had his dog cloned. The former quarterback revealed that his Junie is actually a clone of Lua, a pit bull mix that died in 2023.
Brady’s announcement follows those of celebrities like Paris...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...
By Meagan Parrish, PharmaVoice | 10.10.2025
When CEO Ben Lamm steps into the spotlight, it’s usually to talk about his efforts bringing extinct animals back to life. Once a far-flung idea, Lamm and the company he heads, Colossal Biosciences, have proven they can pull it off...